Long-Term Outcomes and Factors Associated with Mortality in Patients with Moderate to Severe Pulmonary Hypertension in Kenya
References
- Hoeper MM, Humbert M, Souza R, et al. A global view of pulmonary hypertension. Lancet Respir Med. 2016; 4(4): 306–22. DOI: 10.1016/S2213-2600(15)00543-3
- Odero N. The Prevalence of pulmonary arterial hypertension in children with sickle cell disease at Kenyatta National Hospital|UNIVERSITY OF NAIROBI LIBRARY. Secondary The Prevalence of pulmonary arterial hypertension in children with sickle cell disease at Kenyatta National Hospital|UNIVERSITY OF NAIROBI LIBRARY. 2018.
http://uonlibrary.uonbi.ac.ke/content/prevalence-pulmonary-arterial-hypertension-children-sickle-cell-disease-kenyatta-national--0 . - Ilovi EAI-S, Oyoo GO, Ogola EN. Echocardiographic findings in patients with rheumatoid arthritis attending the rheumatology clinic at the Kenyatta National Hospital. 2017; 5.
- Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013; 62(25 Suppl): D34–41. DOI: 10.1016/j.jacc.2013.10.029
- Thienemann F, Dzudie A, Mocumbi AO, et al. The causes, treatment, and outcome of pulmonary hypertension in Africa: Insights from the Pan African Pulmonary Hypertension Cohort (PAPUCO) Registry. Int J Cardiol. 2016; 221: 205–11. DOI: 10.1016/j.ijcard.2016.06.242
- Strange G, Playford D, Stewart S, et al. Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort. Heart. 2012; 98(24): 1805–11. DOI: 10.1136/heartjnl-2012-301992
- George MG, Schieb LJ, Ayala C, et al. Pulmonary hypertension surveillance: United States, 2001 to 2010. Chest. 2014; 146(2): 476–95. DOI: 10.1378/chest.14-0527
- UNAIDS.
Prevention Gap Report. Geneva, Switzerland: United Nations Programme on HIV/AIDS; 2016. Secondary Prevention Gap Report . Geneva, Switzerland: United Nations Programme on HIV/AIDS; 2016.http://www.unaids.org/sites/default/files/media_asset/2016-prevention-gap-report_en.pdf . - Federation. WH. Rheumatic heart disease in Kenya. Heart Beat. Secondary Rheumatic heart disease in Kenya. Heart Beat; 2007.
http://www.world-heart-federation.org/press/heart-beat-e-newsletter/heart-beat-augustseptember-2007/in-this-issue/rheumatic-heart-disease-in-kenya/ . - MoH KW. Kenya stepwise survey for non-communicable diseases risk factors 2015 report. Secondary Kenya stepwise survey for non-communicable diseases risk factors 2015 Report. 2015.
http://aphrc.org/wp-content/uploads/2016/04/Steps-Report-NCD-2015.pdf . - Farber HW, Miller DP, Poms AD, et al. Five-Year outcomes of patients enrolled in the REVEAL Registry. Chest. 2015; 148(4): 1043–54. DOI: 10.1378/chest.15-0300
- Melby SJ, Moon MR, Lindman BR, et al. Impact of pulmonary hypertension on outcomes after aortic valve replacement for aortic valve stenosis. J Thorac Cardiovasc Surg. 2011; 141(6): 1424–30. DOI: 10.1016/j.jtcvs.2011.02.028
- Kelesidis I, Mazurek JA, Saeed W, et al. Effect of nesiritide in isolated right ventricular failure secondary to pulmonary hypertension. Congest Heart Fail. 2012; 18(1): 18–24. DOI: 10.1111/j.1751-7133.2011.00273.x
- Mason JW, Hancock EW, Leonard S. Recommendations for the standardization and interpretation of the electrocardiogram: Part II: Electrocardiography diagnostic statement list: A Scientific Statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. Heart Rhythm. 2007; 4(3): 413–19.
- Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015; 28(1): 1–39.e14. DOI: 10.1016/j.echo.2014.10.003
- Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017; 30(4): 303–71. DOI: 10.1016/j.echo.2017.01.007
- Burton R, Damasceno A, Stewart S, et al. Rationale and design of the Pan African Pulmonary hypertension Cohort (PAPUCO) study: implementing a contemporary registry on pulmonary hypertension in Africa. 2014.
- McGoon MD, Miller DP, REVEAL: a contemporary US pulmonary arterial hypertension registry. 2012.
- Sani MU, Karaye KM, Borodo MM. Prevalence and pattern of rheumatic heart disease in the Nigerian savannah: an echocardiographic study. Cardiovasc J Afr. 2007; 18(5): 295–9.
- Stewart S, Mocumbi AO, Carrington MJ, et al. A not-so-rare form of heart failure in urban black Africans: pathways to right heart failure in the Heart of Soweto Study cohort. Eur J Heart Fail. 2011; 13(10): 1070–7. DOI: 10.1093/eurjhf/hfr108
- Sliwa K, Davison BA, Mayosi BM, et al. Readmission and death after an acute heart failure event: predictors and outcomes in sub-Saharan Africa: results from the THESUS-HF registry. Eur Heart J. 2013; 34(40): 3151–9. DOI: 10.1093/eurheartj/eht393
- Gall H, Felix JF, Schneck FK, et al. The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups. J Heart Lung Transplant. 2017; 36(9): 957–67. DOI: 10.1016/j.healun.2017.02.016
- Marques-Alves P, Baptista R, Marinho da Silva A, et al. Real-world, long-term survival of incident patients with pulmonary arterial hypertension. Rev Port Pneumol (2006). 2017; 23(3): 124–31. DOI: 10.1016/j.rppnen.2017.01.006
- Chang WT, Weng SF, Hsu CH, et al. Prognostic Factors in Patients With Pulmonary Hypertension-A Nationwide Cohort Study. J Am Heart Assoc. 2016; 5(9). DOI: 10.1161/JAHA.116.003579
- Corciova FC, Arsenescu-Georgescu C. Prognostic Factors in Pulmonary Hypertension. Maedica (Buchar). 2012; 7(1): 30–7.
- Zafrir B, Adir Y, Shehadeh W, et al. The association between obesity, mortality and filling pressures in pulmonary hypertension patients; the “obesity paradox”. Respiratory Medicine. 2013; 107(1): 139–46. DOI: 10.1016/j.rmed.2012.10.019
- Caceres JD, Mojadidi M, Eshterhadi P. Mortality In patients with pulmonary hypertension and high body mass index. Am J Respir Crit Care Med. 2014; 189: 1–2.
- Abramowitz MK, Hall CB, Amodu A, et al. Muscle mass, BMI, and mortality among adults in the United States: A population-based cohort study. PLoS One. 2018; 13(4):
e0194697 . DOI: 10.1371/journal.pone.0194697 - Khan SS, Ning H, Wilkins JT, et al. Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity. JAMA Cardiol. 2018; 3(4): 280–87. DOI: 10.1001/jamacardio.2018.0022
- Chang VW, Langa KM, Weir D, et al. The obesity paradox and incident cardiovascular disease: A population-based study. PLoS One. 2017; 12(12):
e0188636 . DOI: 10.1371/journal.pone.0188636 - Forfia PR, Fisher MR, Mathai SC, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med. 2006; 174(9): 1034–41. DOI: 10.1164/rccm.200604-547OC
DOI: https://doi.org/10.5334/gh.384 | Journal eISSN: 2211-8179
Language: English
Submitted on: Mar 25, 2019
Accepted on: Nov 19, 2019
Published on: Feb 6, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
© 2020 Mzee Ngunga, Abdulaziz Mansur Abeid, Jeilan Mohamed, Anders Barasa, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.